116 related articles for article (PubMed ID: 20728036)
1. Control of life-threatening head and neck hemorrhage after dental extractions: a case report.
Lieberman BL; Kennedy MK; Lorenzo DR; Reed LJ; Adamo AK; Cardo VA; Badner VM
J Oral Maxillofac Surg; 2010 Sep; 68(9):2311-9. PubMed ID: 20728036
[No Abstract] [Full Text] [Related]
2. [Hemostatic drugs in a patient with antiphospholipid syndrome and clinically significant perioperative bleeding].
Martínez Rodríguez E; Mato M; Otero J; Ferri JR; Gonzálvez A; Torres LM
Rev Esp Anestesiol Reanim; 2006 Mar; 53(3):195-7. PubMed ID: 16671265
[No Abstract] [Full Text] [Related]
3. Use of recombinant factor VII for tooth extractions in a patient with severe congenital factor VII deficiency: a case report.
Weinstock RJ; Onyejiuwa A; Shnayder G; Clarkson EI
J Am Dent Assoc; 2015 Apr; 146(4):271-5. PubMed ID: 25819659
[TBL] [Abstract][Full Text] [Related]
4. Correction by desmopressin of bleeding following dental extraction in a patient under antithrombotic therapy.
Cesar JM; Iturriaga TM
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Aug; 104(2):151. PubMed ID: 17560143
[No Abstract] [Full Text] [Related]
5. Life-threatening bleeding from refractory acquired FVIII inhibitor successfully treated with rituximab.
Jy W; Gagliano-DeCesare T; Kett DH; Horstman LL; Jimenez JJ; Ruiz-Dayao Z; Santos ES; Ahn YS
Acta Haematol; 2003; 109(4):206-8. PubMed ID: 12853696
[No Abstract] [Full Text] [Related]
6. Intraoral hemostasis using a recombinant activated factor VII preparation in a hemophilia a patient with inhibitor.
Morimoto Y; Yoshioka A; Shima M; Kirita T
J Oral Maxillofac Surg; 2003 Sep; 61(9):1095-7. PubMed ID: 12966487
[No Abstract] [Full Text] [Related]
7. [The "Seville" Consensus Document on Alternatives to Allogenic Blood Transfusion. Sociedades españolas de Anestesiología (SEDAR), Medicina Intensiva (SEMICYUC), Hematología y Hemoterapia (AEHH), Transfusión sanguínea (SETS) Trombosis y Hemostasia (SETH)].
Alberca I; Asuero MS; Bóveda JL; Carpio N; Contreras E; Fernández-Mondéjar E; Forteza A; García-Erce JA; García de Lorenzo A; Gomar C; Gómez A; Llau JV; López-Fernández MF; Moral V; Muñoz M; Páramo JA; Torrabadella P; Quintana M; Sánchez C
Med Clin (Barc); 2006 Jul; 127 Suppl 1():3-20. PubMed ID: 17020674
[TBL] [Abstract][Full Text] [Related]
8. Management of Surgical Third Lower Molar Extraction and Postoperative Progress in Patients With Factor VII Deficiency: A Clinical Protocol and Focus on This Rare Pathologic Entity.
Passarelli PC; Pasquantonio G; D'Addona A
J Oral Maxillofac Surg; 2017 Oct; 75(10):2070.e1-2070.e4. PubMed ID: 28672139
[TBL] [Abstract][Full Text] [Related]
9. Letter by Al-Ruzzeh and Navia regarding article, "Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the setting of bleeding after cardiac surgery".
Al-Ruzzeh S; Navia JL
Circulation; 2010 Mar; 121(9):e234. PubMed ID: 20212289
[No Abstract] [Full Text] [Related]
10. Prophylactic effect of recombinant factor VIIa with congenital factor VII deficiency.
Karimi M; Shafieian R
Haemophilia; 2008 Jul; 14(4):851-2. PubMed ID: 18399984
[No Abstract] [Full Text] [Related]
11. Postoperative bleeding with factor VII deficiency: case report.
Cheng JC; Wong RW; Yan BS
Aust Dent J; 1998 Dec; 43(6):382-4. PubMed ID: 9973704
[TBL] [Abstract][Full Text] [Related]
12. Congenital deficiency of factor VII in the light of two cases.
Urasiński I; Biernat J
Pol Med J; 1971; 10(3):605-10. PubMed ID: 5124130
[No Abstract] [Full Text] [Related]
13. Pharmacologic alternatives to transfusion.
Ness PM
Vox Sang; 2002 Aug; 83 Suppl 1():3-6. PubMed ID: 12617091
[No Abstract] [Full Text] [Related]
14. Use of recombinant factor VIIa as a rescue treatment for intractable bleeding following repeat aortic arch repair.
Stratmann G; Russell IA; Merrick SH
Ann Thorac Surg; 2003 Dec; 76(6):2094-7. PubMed ID: 14667657
[TBL] [Abstract][Full Text] [Related]
15. DDAVP and EACA used for minor oral surgery in von Willebrand disease.
Williamson R; Eggleston DJ
Aust Dent J; 1988 Feb; 33(1):32-6. PubMed ID: 2970252
[No Abstract] [Full Text] [Related]
16. Perioperative hemostatic management in the cirrhotic patient: a position paper on behalf of the Liver Intensive Care Group of Europe (LICAGE).
Biancofiore G; Blasi A; De Boer MT; Franchini M; Hartmann M; Lisman T; Liumbruno GM; Porte RJ; Saner F; Senzolo M; Werner MJ
Minerva Anestesiol; 2019 Jul; 85(7):782-798. PubMed ID: 30945514
[TBL] [Abstract][Full Text] [Related]
17. [Successful use of recombinant factor VIIa in the control of a massive bleeding in two patients with biventricular assist device (Thoratec)].
Fritsch N; Pouquet O; Roux B; Abdelmoumen Y; Janvier G
Ann Fr Anesth Reanim; 2010 Jan; 29(1):45-7. PubMed ID: 20080378
[TBL] [Abstract][Full Text] [Related]
18. [Recombinant activated factor VII for perioperative bleeding].
López R; Aeschlimann N; Carvajal C; Lema G
Rev Med Chil; 2009 Jun; 137(6):837-43. PubMed ID: 19746288
[TBL] [Abstract][Full Text] [Related]
19. Desmopressin acetate prophylaxis in a patient with hemophilia A: report of case.
Herrin RA; Boyd JF
J Am Dent Assoc; 1988 Oct; 117(5):593-4. PubMed ID: 2976070
[TBL] [Abstract][Full Text] [Related]
20. Haemostatic management of intraoral bleeding in patients with von Willebrand disease.
Morimoto Y; Yoshioka A; Sugimoto M; Imai Y; Kirita T
Oral Dis; 2005 Jul; 11(4):243-8. PubMed ID: 15984956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
